As part of our Future Cities business, we invest in renewable energy, digital infrastructure and urban projects, which are socially as well as economically beneficial, using long-term capital to create a better world.
Part of Future Cities, Bruntwood SciTech provides environments and ecosystems to support companies in the science and technology sector to form, collaborate, scale and grow, creating high-value jobs for the UK economy.
Part of Bruntwood SciTech, the Mereside Life Science Campus at Alderley Park in Cheshire has been making the headlines over the past month as the second of the government’s coronavirus ‘Lighthouse Labs’ to become fully operational, with ambitions to increase testing capacity to up to 100,000 samples each day.
Alderley Park is home to the UK’s largest single-site life science campus, with particular expertise in areas such as cancer, drug discovery, diagnostics, infection and anti-microbial resistance. The site is host to 200 organisations, from start-ups like Apconix, a toxicology company which researches the safety of drugs as they approach the market, to national institutes such as the Manchester division of Cancer Research UK, and even multi-nationals like Evotec, a drug discovery and development company with additional sites in Europe and the US.
The government’s three labs – in Alderley Park, Milton Keynes and Glasgow – are being run through a partnership between the Department of Health and Social Care, the UK Biocentre, the University of Glasgow and Medicines Discovery Catapult, a UK Research and Innovation-funded medicine research centre based at Alderley Park and also responsible for coordinating the new national laboratory network. Because of the wealth of expertise at Alderley Park, many of the employees are also volunteering in the testing labs.